ANI Pharmaceuticals Inc (NAS:ANIP)
$ 84.49 +1.269 (+1.52%) Market Cap: 1.92 Bil Enterprise Value: 2.21 Bil PE Ratio: 21.39 PB Ratio: 3.44 GF Score: 77/100

ANI Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2026 / 07:00 PM GMT
Release Date Price: $76.29 (+0.43%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ANIP.OQ - ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc at Barclays Global Healthcare Conference
Mar 11, 2026 / 07:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, good afternoon, everyone.

Thank you for joining us. For our next presentation, we're excited to have ANI Pharmaceuticals here with us. Our representative of the company, to my right is Nikhil Lalwani. He's the President and Chief Executive Officer of the company and to his right, Steven Carey is the Chief Financial Officer of the company. For those of you who don't know me, I'll just quickly introduce myself. My name is is Glenn Santangelo. I'm the analyst at Barclays responsible for the specialty pharmaceuticals sector, among a few other things. But, again, we're very happy to have you here, Nikhil and Steven. So thank you guys very much for for taking the time out of your schedules.

-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot